Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 3 53Phase 1 18Phase 2/3 4Phase NA 3Phase 1/2 3Phase 4 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 45NIH 7NETWORK 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2CNS 1

Conditions

Fallopian Tube Neoplasms 2Vomiting 1Spinal Cord Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Nausea 1Central Nervous System Neoplasms 1Brenner Tumor 1Brain Neoplasms 1

Interventions

Radiotherapy 10Early Intervention, Educational 7Standard of Care 6Magnetic Resonance Spectroscopy 6Interviews as Topic 6Educational Status 6Radiotherapy, Conformal 5Practice Guidelines as Topic 5Methods 5Cyclophosphamide 5Vincristine 4Psychiatric Rehabilitation 4Cisplatin 4Brachytherapy 4Biopsy 4Surgical Procedures, Operative 3Specimen Handling 3Radiosurgery 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Dexamethasone 3Counseling 3Carboplatin 3pegaspargase 2motexafin gadolinium 2etoposide phosphate 2Radiofrequency Ablation 2Radiation 2Preoperative Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × NETWORK × Carboplatin × Clear all
NCT06466382 2026-05-05

OVPrecision

Swiss GO Trial Group

Phase NA Recruiting
60 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

NCT00077207 2018-05-16

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Children's Oncology Group

Phase NA Completed
66 enrolled 13 charts
CNS

Brain Neoplasms, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡